Our team is headed to #bio2023 in Boston June 5-8! Our CEO Choon-Peng (Choon) Ng and our Senior Director, Business Development Christopher Alfonso will be on site at the convention this year. If you are interested in meeting with them to learn more about our Deep...
Ayesha Siddiqui from BioSpectrum Asia spoke with our CEO and Co-Founder Choon-Peng (Choon) Ng about the progress around cancer research in Asia for her recent piece. See what Choon had to say in the full piece linked below....
Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and develop novel TCR-based therapeutics against a diverse range of tumor antigens. You can see the full...
Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and develop novel TCR-based therapeutics against a diverse range of tumor antigens. You can see the full...
Are you attending the 41st Annual JPM Healthcare Conference in San Francisco next month? Our CEO, Choon-Peng Ng, and Dan MacLeod, VP Discovery, will be on-site January 9-10th. We look forward to connecting with industry peers, sharing insights, and discussing...
